I was recently asked by wire service, Reuters Health, my view on a new study showing that adjusting enrollment processes for medical research can help to reduce therapeutic misconception.
This study provides good evidence for existing hypotheses that therapeutic misconception has little effect on willingness to enrol in trials. Therapeutic misconception is primarily a problem for the duty of veracity owed by investigators to their patients, and those patients’ rights to dignity and autonomy.
Not only does this study suggest a way forward for reducing therapeutic misconception, it also shows that informed consent processes designed for patients to make therapeutic choices may not be appropriate for participants in clinical trials. Efforts to dispel therapeutic misconception will only benefit a worthwhile clinical trial.
Article and further comment available at Educational Intervention Limits Therapeutic Misconception About Clinical Trials – Medscape – Sep 25, 2017. [login wall]